Cargando…
Delivery of recombinant SARS-CoV-2 envelope protein into human cells
SARS-CoV-2 envelope protein (S2-E) is a conserved membrane protein that is essential to coronavirus assembly and budding. Here, we describe the recombinant expression and purification of S2-E into amphipol-class amphipathic polymer solutions. The physical properties of amphipols underpin their abili...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899446/ https://www.ncbi.nlm.nih.gov/pubmed/33619482 http://dx.doi.org/10.1101/2021.02.18.431684 |
_version_ | 1783654044398518272 |
---|---|
author | Hutchison, James M. Capone, Ricardo Luu, Dustin D. Hadziselimovic, Arina Van Horn, Wade D. Sanders, Charles R. |
author_facet | Hutchison, James M. Capone, Ricardo Luu, Dustin D. Hadziselimovic, Arina Van Horn, Wade D. Sanders, Charles R. |
author_sort | Hutchison, James M. |
collection | PubMed |
description | SARS-CoV-2 envelope protein (S2-E) is a conserved membrane protein that is essential to coronavirus assembly and budding. Here, we describe the recombinant expression and purification of S2-E into amphipol-class amphipathic polymer solutions. The physical properties of amphipols underpin their ability to solubilize and stabilize membrane proteins without disrupting membranes. Amphipol delivery of S2-E to pre-formed planar bilayers results in spontaneous membrane integration and formation of viroporin ion channels. Amphipol delivery of the S2-E protein to human cells results in membrane integration followed by retrograde trafficking to a location adjacent to the endoplasmic reticulum-to-Golgi intermediate compartment (ERGIC) and the Golgi, which are the sites of coronavirus replication. Delivery of S2-E to cells enables both chemical biological approaches for future studies of SARS-CoV-2 pathogenesis and development of “Trojan Horse” anti-viral therapies. This work also establishes a paradigm for amphipol-mediated delivery of membrane proteins to cells. |
format | Online Article Text |
id | pubmed-7899446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-78994462021-02-23 Delivery of recombinant SARS-CoV-2 envelope protein into human cells Hutchison, James M. Capone, Ricardo Luu, Dustin D. Hadziselimovic, Arina Van Horn, Wade D. Sanders, Charles R. bioRxiv Article SARS-CoV-2 envelope protein (S2-E) is a conserved membrane protein that is essential to coronavirus assembly and budding. Here, we describe the recombinant expression and purification of S2-E into amphipol-class amphipathic polymer solutions. The physical properties of amphipols underpin their ability to solubilize and stabilize membrane proteins without disrupting membranes. Amphipol delivery of S2-E to pre-formed planar bilayers results in spontaneous membrane integration and formation of viroporin ion channels. Amphipol delivery of the S2-E protein to human cells results in membrane integration followed by retrograde trafficking to a location adjacent to the endoplasmic reticulum-to-Golgi intermediate compartment (ERGIC) and the Golgi, which are the sites of coronavirus replication. Delivery of S2-E to cells enables both chemical biological approaches for future studies of SARS-CoV-2 pathogenesis and development of “Trojan Horse” anti-viral therapies. This work also establishes a paradigm for amphipol-mediated delivery of membrane proteins to cells. Cold Spring Harbor Laboratory 2021-02-19 /pmc/articles/PMC7899446/ /pubmed/33619482 http://dx.doi.org/10.1101/2021.02.18.431684 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Hutchison, James M. Capone, Ricardo Luu, Dustin D. Hadziselimovic, Arina Van Horn, Wade D. Sanders, Charles R. Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title | Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title_full | Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title_fullStr | Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title_full_unstemmed | Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title_short | Delivery of recombinant SARS-CoV-2 envelope protein into human cells |
title_sort | delivery of recombinant sars-cov-2 envelope protein into human cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899446/ https://www.ncbi.nlm.nih.gov/pubmed/33619482 http://dx.doi.org/10.1101/2021.02.18.431684 |
work_keys_str_mv | AT hutchisonjamesm deliveryofrecombinantsarscov2envelopeproteinintohumancells AT caponericardo deliveryofrecombinantsarscov2envelopeproteinintohumancells AT luudustind deliveryofrecombinantsarscov2envelopeproteinintohumancells AT hadziselimovicarina deliveryofrecombinantsarscov2envelopeproteinintohumancells AT vanhornwaded deliveryofrecombinantsarscov2envelopeproteinintohumancells AT sanderscharlesr deliveryofrecombinantsarscov2envelopeproteinintohumancells |